Targeting Lysophospholipid Acid Receptor 1 and ROCK Kinases Promotes Antiviral Innate Immunity

Investigators found that viral infection promoted the G protein–coupled receptor lysophosphatidic acid (LPA)1 expression, and LPA restrained type I/III interferon production through LPA1.